What does this research mean for the field?

Opioid recalls in the United States reflect significant manufacturing or quality assurance problems that undermine product reliability. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The research aims to analyze FDA drug recalls related to opioid medications and identify manufacturing issues.

February 25, 2026

View Full Paper

Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002-2025.

Key Points

The research aims to analyze FDA drug recalls related to opioid medications and identify manufacturing issues.
Analysis of FDA recall data from 2002 to 2025
Assessment of manufacturing and quality assurance problems
Review of quantitative data for recalling practices
Identified trends in opioid medication recalls over the years
Highlighted specific quality assurance issues contributing to recalls
Emphasized the need for improved recall reporting in the pharmaceutical industry

Abstract

Opioid recalls reflect manufacturing or quality assurance problems that may undermine product reliability. More complete recall reporting, including quantitative data, would support efforts to reduce risks associated with pharmaceutical quality failures.

Perguntar à IA

Bookmark

View Full Paper

Perguntar à IA

Bookmark

View Full Paper

Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002-2025.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider